Jaguar Health seeks shareholder approval to expand stock incentive plan to 378,859 shares

• Jaguar Health seeks shareholder approval November 6, 2026, to amend its 2014 Stock Incentive Plan, increasing authorized shares to 378,859.
• A sixfold reserve adjustment takes effect immediately following the meeting to reflect the Series R Preferred Stock Dividend.
• Passage would bring available shares to 2,273,154, preserving approximately 14% of fully diluted common shares outstanding as of September 30, 2026.
• Rejection would leave 4,260 shares available; the adjusted incentive stock option limit would be 163,998 shares under either outcome.
• The board's voting recommendations remain unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-436334), on October 28, 2026, and is solely responsible for the information contained therein.